Investment Thesis

Leidos Holdings, Inc. (LDOS) presents a compelling BUY opportunity at current prices of $123.69 due to its robust positioning in high-growth sectors such as defense, civil services, and health. The market is undervaluing the company's long-term growth potential, particularly in a geopolitical environment that continues to prioritize national security and technological advancement. Given the increasing demand for advanced solutions in defense and health, LDOS is well-positioned to capitalize on these trends, making its current valuation an attractive entry point.

Competitive Moat

characterized by intangible assets, particularly its established relationships with government agencies and a reputation for delivering critical national security solutions. This regulatory advantage, combined with high switching costs for customers reliant on their sophisticated systems and services, creates significant barriers for new entrants. The durability of this moat is expected to remain robust over the next 5-10 years, although emerging competitors leveraging advanced technology in cybersecurity and data analytics pose threats that the company must continuously address.

Growth Engine

Future revenue growth for LDOS is primarily driven by expanding its addressable market in defense and health solutions, which are projected to grow significantly due to increased government spending and the rising emphasis on public health infrastructure. The total addressable market (TAM) for defense and health services alone is estimated to exceed $500 billion over the next decade. LDOS is likely to achieve this growth through a combination of organic expansion in existing contracts and strategic acquisitions that enhance its technological capabilities. The company is gaining market share, particularly in cybersecurity and data analytics, where demand is surging.